Spruce Biosciences, Inc. Common Stock
Symbol: SPRB (NASDAQ)
142.38
▲ (9.59%) 12.455
Company Description:
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.
Key Stats
- Today's Open: $131.03
- Today's High: $148.383
- Today's Low: $129.755
- Today's Volume: 135.04K
- Yesterday Close: $129.92
- Yesterday High: $140.45
- Yesterday Low: $128.44
- Yesterday Volume: 63.46K
- Last Min Volume: 2.04K
- Last Min High: $142.375
- Last Min Low: $142.375
- Last Min VWAP: $142.375
Company Profile
- Name: Spruce Biosciences, Inc. Common Stock
- Website: https://www.sprucebiosciences.com
- Listed Date: 2020-10-09
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001683553
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $75.08M
- Round Lot: 100
- Outstanding Shares: 563.49K
- Asset Type: CS
RECENT FILINGS FOR SPRB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-22 | 4 | View |
| 2025-10-22 | 4 | View |
| 2025-10-17 | 8-K | View |
| 2025-10-17 | D | View |
| 2025-10-16 | SCHEDULE 13G | View |
| 2025-10-15 | 4 | View |
| 2025-10-15 | 3 | View |
| 2025-10-15 | SCHEDULE 13G | View |
| 2025-10-09 | SCHEDULE 13D/A | View |
| 2025-10-08 | 4 | View |
| 2025-10-08 | 3 | View |
| 2025-10-08 | 8-K | View |
| 2025-10-08 | SCHEDULE 13G | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-07-24 | 4 | View |
| 2025-07-24 | 4 | View |
| 2025-07-24 | 4 | View |
Latest News on SPRB